NMPA Approval

Trastuzumab Deruxtecan for Injection

Approval Number

国药准字SJ20230005

Registration Date

March 24, 2023

Drug Information

Generic Name

注射用德曲妥珠单抗

Trade Name

优赫得

Dosage Form

注射剂

Strength

100mg/瓶

Drug Type

生物制品

Registration Date

March 24, 2023

Expiry Date

February 20, 2028

Company Address

Zielstattstrasse 48, 81379 Munich, Germany

Company Address

Kantstrasse 2, Halle/Westfalen 33790, Germany

Empowering clinical research with data-driven insights and AI-powered tools.

注射用德曲妥珠单抗 - NMPA 批准文号 | MedPath